Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;185(4):1294-1303.
doi: 10.1002/ajmg.a.62097. Epub 2021 Feb 2.

Surveillance guidelines for children with trisomy 18

Affiliations
Review

Surveillance guidelines for children with trisomy 18

Jeffrey W Kepple et al. Am J Med Genet A. 2021 Apr.

Abstract

Trisomy 18 is the second most common aneuploidy syndromes in live born infants. It is associated with high mortality rates, estimated to be 75%-95% in the first year of life, as well as significant morbidity in survivors. The low survival is largely due to the high prevalence of severe congenital anomalies in infants with this diagnosis. However, interventions to repair or palliate those life-threatening anomalies are being performed at a higher rate for these infants, resulting in increased rates of survival beyond the first year of life. While it is well documented that trisomy 18 is associated with several cardiac malformations, these patients also have respiratory, neurological, neoplastic, genitourinary, abdominal, otolaryngologic, and orthopedic complications that can impact their quality of life. The goal of this review is to present a comprehensive description of complications in children with trisomy 18 to aid in the development of monitoring and treatment guidelines for the increasing number of providers who will be caring for these patients throughout their lives. Where the evidence is available, this review presents screening recommendations to allow for more rapid detection and documentation of these complications.

Keywords: Edward's syndrome; hepatoblastoma; management; screening.

PubMed Disclaimer

References

REFERENCES

    1. Anderson, C. E., Punnett, H. H., Huff, V., & de Chadarévian, J. P. (2003). Characterization of a Wilms tumor in a 9-year-old girl with trisomy 18. American Journal of Medical Genetics. Part A, 121A(1), 52-55. https://doi.org/10.1002/ajmg.a.20141
    1. Andrews, S. E., Downey, A. G., Showalter, D. S., Fitzgerald, H., Showalter, V. P., Carey, J. C., & Hulac, P. (2016). Shared decision making and the pathways approach in the prenatal and postnatal management of the trisomy 13 and trisomy 18 syndromes. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 172(3), 257-263. https://doi.org/10.1002/ajmg.c.31524
    1. Barnes, A., & Carey, J. (2018). Care of the infant and child with trisomy 18 or trisomy 13 (4th ed.). Omaha, NE: Munroe-Meyer Institute for Genetics and Rehabilitation.
    1. Baty, B., Blackburn, B., & Carey, J. (1994). Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. American Journal of Medical Genetics, 49, 175-188. https://doi.org/10.1002/ajmg.1320490204
    1. Baty, B. J., Jorde, L. B., Blackburn, B. L., & Carey, J. C. (1994). Natural history of trisomy 18 and trisomy 13: II. Psychomotor development. American Journal of Medical Genetics, 49(2), 189-194. https://doi.org/10.1002/ajmg.1320490205

LinkOut - more resources